Keating Financial Advisory Services »

Cytek Biosciences shares owned by Keating Financial Advisory Services

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Keating Financial Advisory Services from 13F filings

Historical chart of Keating Financial Advisory Services investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Keating Financial Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Keating Financial Advisory Services

Quarter filed Position value Share count Share price at filing
2026-03-31 $376 86 4.37

More positions owned by Keating Financial Advisory Services

Apple (AAPL)
Dimensional Us Core Equity Market Etf Us Core Eqt Mkt (DFAU)
NVIDIA Corporation (NVDA)
Vanguard Index Funds S&p 500 Etf S&p 500 Etf Shs (VOO)
Dimensional Us High Profitability Etf Us High Profitab (DUHP)
State Street Spdr S&p 500 Etf Trust Tr Unit (SPY)
Dimensional International Core Equity Market Etf Intl Core Eqt Mk (DFAI)
Microsoft Corporation (MSFT)
Dimensional Core Fixed Income Etf Core Fixed Incom (DFCF)
Invesco S&p 500 Momentum Etf S&p 500 Momntm (SPMO)
Schwab U.s. Large-cap Growth Etf Us Lcap Gr Etf (SCHG)
Invesco Qqq Trust Unit Ser 1 (QQQ)
Amazon (AMZN)
Dimensional International High Profitability Etf Intl High Profit (DIHP)
Dimensional Us Core Equity 1 Etf Us Core Equity 1 (DCOR)

View all positions for Keating Financial Advisory Services

Top funds holding Cytek Biosciences

BlackRock
Hillhouse Capital Advisors
Millennium Management
Robeco Investment Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Dimensional Fund Advisors
Goldman Sachs Group
Vanguard Portfolio Management
Morgan Stanley
Royce & Associates
Brown Capital Management
Russell Investments
Charles Schwab Investment Management

View all funds holding Cytek Biosciences